JLK Inc
KOSDAQ:322510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of JLK Inc (322510) under the Base Case is 393.84 KRW per share. Compared with the current market price of 3 740 KRW, the stock appears Overvalued by 89% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What JLK Does
JLK Inc is a South Korean medical software company that makes artificial intelligence tools for reading medical images. Its products help doctors look at CT and MRI scans, especially in emergency care such as stroke detection, brain imaging, and related neurological conditions. The company sells software that can flag abnormal findings, support faster decisions, and help hospitals handle scans more efficiently.
- Headquarters
- Korea KR
- IPO date
- Dec 11, 2019
Continue Research
Decided on JLK? Get an email when JLK Inc reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one JLK Inc stock?
The intrinsic value for JLK Inc (322510) under the Base Case is 393.84 KRW.
Is JLK Inc stock undervalued or overvalued?
Compared with the current market price of 3 740 KRW, the stock appears Overvalued by 89% .